Bailard’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.5M Sell
147,802
-1,209
-0.8% -$282K 0.76% 32
2026
Q1
$36.4M Sell
149,011
-428
-0.3% -$99.7K 0.84% 28
2025
Q4
$30.9M Sell
149,439
-3,105
-2% -$614K 0.68% 34
2025
Q3
$28.3M Sell
152,544
-1,762
-1% -$302K 0.61% 37
2025
Q2
$23.6M Buy
154,306
+13,012
+9% +$2M 0.55% 44
2025
Q1
$23.4M Buy
141,294
+6,087
+5% +$952K 0.6% 38
2024
Q4
$19.6M Sell
135,207
-5,008
-4% -$776K 0.5% 44
2024
Q3
$22.7M Sell
140,215
-113
-0.1% -$18K 0.59% 41
2024
Q2
$20.5M Sell
140,328
-5,102
-4% -$759K 0.57% 42
2024
Q1
$23M Sell
145,430
-2,433
-2% -$387K 0.64% 36
2023
Q4
$23.2M Sell
147,863
-3,014
-2% -$462K 0.69% 32
2023
Q3
$23.5M Buy
150,877
+17,789
+13% +$2.94M 0.78% 30
2023
Q2
$22M Buy
133,088
+1,435
+1% +$232K 0.77% 27
2023
Q1
$20.4M Sell
131,653
-338
-0.3% -$54.6K 0.73% 29
2022
Q4
$23.3M Buy
131,991
+321
+0.2% +$55.4K 0.89% 25
2022
Q3
$21.5M Sell
131,670
-120
-0.1% -$20.3K 0.89% 23
2022
Q2
$23.4M Buy
131,790
+11,700
+10% +$2.08M 0.92% 23
2022
Q1
$21.3M Buy
120,090
+332
+0.3% +$56.5K 0.72% 30
2021
Q4
$20.5M Sell
119,758
-993
-0.8% -$163K 0.65% 33
2021
Q3
$19.5M Buy
120,751
+302
+0.3% +$51.5K 0.67% 32
2021
Q2
$19.8M Sell
120,449
-1,972
-2% -$326K 0.69% 28
2021
Q1
$20.1M Buy
122,421
+18,890
+18% +$3.06M 0.75% 29
2020
Q4
$16.3M Sell
103,531
-1,011
-1% -$149K 0.74% 28
2020
Q3
$15.6M Buy
104,542
+684
+0.7% +$101K 0.81% 26
2020
Q2
$14.6M Buy
103,858
+2,159
+2% +$315K 0.82% 26
2020
Q1
$13.3M Buy
101,699
+5,623
+6% +$798K 0.95% 22
2019
Q4
$14M Buy
96,076
+4,483
+5% +$608K 0.79% 25
2019
Q3
$11.8M Sell
91,593
-1,471
-2% -$194K 0.72% 25
2019
Q2
$13M Sell
93,064
-2,615
-3% -$362K 0.79% 22
2019
Q1
$13.4M Sell
95,679
-1,337
-1% -$179K 0.83% 22
2018
Q4
$12.5M Buy
97,016
+241
+0.2% +$33.6K 0.85% 23
2018
Q3
$13.4M Sell
96,775
-1,125
-1% -$149K 0.78% 20
2018
Q2
$11.9M Sell
97,900
-1,116
-1% -$139K 0.71% 21
2018
Q1
$12.7M Buy
99,016
+2,606
+3% +$352K 0.81% 17
2017
Q4
$13.5M Sell
96,410
-1,850
-2% -$258K 0.85% 18
2017
Q3
$12.8M Buy
98,260
+973
+1% +$129K 0.99% 18
2017
Q2
$12.9M Buy
97,287
+2,239
+2% +$286K 1.04% 17
2017
Q1
$11.8M Sell
95,048
-1,964
-2% -$235K 0.98% 18
2016
Q4
$11.2M Buy
97,012
+1,218
+1% +$141K 1.03% 17
2016
Q3
$11.3M Buy
95,794
+26,176
+38% +$3.18M 1.04% 15
2016
Q2
$8.45M Buy
69,618
+33,803
+94% +$3.84M 1% 14
2016
Q1
$3.88M Buy
+35,815
New +$3.71M 0.54% 30
2015
Q4
Sell
-35,125
Closed -$3.28M 278
2015
Q3
$3.28M Sell
35,125
-636
-2% -$61.5K 0.51% 29
2015
Q2
$3.48M Sell
35,761
-5,038
-12% -$505K 0.54% 27
2015
Q1
$4.1M Buy
40,799
+600
+1% +$61K 0.57% 23
2014
Q4
$4.2M Buy
40,199
+28
+0.1% +$2.95K 0.59% 22
2014
Q3
$4.28M Sell
40,171
-1,467
-4% -$152K 0.66% 21
2014
Q2
$4.36M Buy
41,638
+2,265
+6% +$229K 0.67% 21
2014
Q1
$3.87M Sell
39,373
-14
-0% -$1.3K 0.61% 22
2013
Q4
$3.61M Sell
39,387
-5,898
-13% -$544K 0.58% 27
2013
Q3
$3.93M Sell
45,285
-16,700
-27% -$1.5M 0.75% 22
2013
Q2
$5.32M Buy
+61,985
New +$5.26M 0.97% 14

Other funds holding JNJ

Bailard's JNJ Position: Q2 2026 in Review

Bailard reduced its Johnson & Johnson (JNJ) stake by 0.81% in Q2 2026, selling an estimated $282K and leaving 147,802 shares worth $37.5M. The position accounts for 0.76% of the portfolio, ranked #32.

Bailard first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Bailard held 147,802 shares of Johnson & Johnson worth $37.5M as of Q2 2026.
  • Bailard sold 1,209 Johnson & Johnson shares in Q2 2026, an estimated $282K.
  • Johnson & Johnson made up 0.76% of Bailard's portfolio in Q2 2026, its #32 holding.
  • Bailard first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.